Philadelphia, PA, United States of America

Geoffrey Golding

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Proteotech Inc.. Active years: 2014.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Geoffrey Golding. Retrieved from https://idiyas.com/inventor/geoffrey-golding

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

Average Co-Inventor Count = 12.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2014

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Geoffrey Golding: Innovator in Neurodegenerative Disease Treatment

Introduction

Geoffrey Golding is a notable inventor based in Philadelphia, PA (US). He has made significant contributions to the field of neurodegenerative diseases through his innovative research and development of therapeutic compounds.

Latest Patents

Golding holds a patent for "Compounds for the treatment of neurodegenerative diseases." This patent specifically addresses compounds and their pharmaceutically acceptable salts for the treatment of synucleinopathies, such as Parkinson's disease, and tauopathies. He has 1 patent to his name, showcasing his commitment to advancing medical science.

Career Highlights

Golding is associated with Proteotech Inc., where he applies his expertise to develop solutions for complex health issues. His work focuses on creating effective treatments that can improve the quality of life for individuals suffering from neurodegenerative conditions.

Collaborations

Throughout his career, Golding has collaborated with talented professionals, including Luke A. Esposito and Marisa C. Yadon. These partnerships have enhanced his research efforts and contributed to the advancement of innovative treatments.

Conclusion

Geoffrey Golding's work in the field of neurodegenerative diseases exemplifies the impact of innovation in medicine. His dedication to developing effective treatments is commendable and highlights the importance of continued research in this critical area.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…